These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33736833)

  • 1. Prasugrel Versus Ticagrelor in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Kow CS; Zaihan AF; Hasan SS
    J Am Coll Cardiol; 2021 Mar; 77(11):1483-1484. PubMed ID: 33736833
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Prasugrel Versus Ticagrelor in Non-ST-Segment-Elevation Acute Coronary Syndrome.
    Neumann FJ; Valina C; Kastrati A
    J Am Coll Cardiol; 2021 Mar; 77(11):1484. PubMed ID: 33736834
    [No Abstract]   [Full Text] [Related]  

  • 3. [The ISAR-REACT 5 trial: is there a winner between prasugrel and ticagrelor in acute coronary syndromes?].
    Ferlini M; Galvani M; Visconti LO
    G Ital Cardiol (Rome); 2020 Mar; 21(3):171-174. PubMed ID: 32100728
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized, Crossover Trial.
    Jeong HS; Hong SJ; Cho SA; Kim JH; Cho JY; Lee SH; Joo HJ; Park JH; Yu CW; Lim DS
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1646-1658. PubMed ID: 28838475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis.
    Wen M; Li Y; Qu X; Zhu Y; Tian L; Shen Z; Yang X; Shi X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):430. PubMed ID: 33004000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.
    Sardella G; Mancone M; Stio RE; Cavallo E; Di Roma A; Colantonio R; Calcagno S
    Circulation; 2017 Aug; 136(6):602-604. PubMed ID: 28784829
    [No Abstract]   [Full Text] [Related]  

  • 7. Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.
    Puel V; Théophile H; Godard I; Raymond N; Miremont-Salamé G; Gosse P; Pépin JL; Pariente A
    Br J Clin Pharmacol; 2019 Aug; 85(8):1855-1858. PubMed ID: 31206207
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes.
    Ndrepepa G; Holdenrieder S; Bernlochner I; Kastrati A
    Clin Res Cardiol; 2022 Jul; 111(7):838-842. PubMed ID: 34850261
    [No Abstract]   [Full Text] [Related]  

  • 9. Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
    Collet JP; Thiele H
    Eur Heart J; 2021 Jul; 42(26):2611-2612. PubMed ID: 33205156
    [No Abstract]   [Full Text] [Related]  

  • 10. Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?
    Kow CS; Zaihan AF; Hasan SS
    Eur Heart J; 2021 Jul; 42(26):2609-2610. PubMed ID: 33205147
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.
    Bonhomme F; Bonvini R; Reny JL; Poncet A; Fontana P
    Platelets; 2015; 26(4):324-30. PubMed ID: 25905916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor or Prasugrel in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    Valina C; Neumann FJ; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Aytekin A; Richardt G; Witzenbichler B; Sibbing D; Cassese S; Angiolillo DJ; Kufner S; Liebetrau C; Hamm CW; Xhepa E; Hapfelmeier A; Sager HB; Wustrow I; Joner M; Trenk D; Laugwitz KL; Schunkert H; Schüpke S; Kastrati A
    J Am Coll Cardiol; 2020 Nov; 76(21):2436-2446. PubMed ID: 33213722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.
    Ariotti S; Ortega-Paz L; van Leeuwen M; Brugaletta S; Leonardi S; Akkerhuis KM; Rimoldi SF; Janssens G; Gianni U; van den Berge JC; Karagiannis A; Windecker S; Valgimigli M;
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1576-1586. PubMed ID: 29805112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of body size on platelet function in patients with acute coronary syndrome on dual antiplatelet therapy.
    Panzer B; Wadowski PP; Huber K; Panzer S; Gremmel T
    Vascul Pharmacol; 2022 Oct; 146():107089. PubMed ID: 35870771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Ticagrelor Versus Prasugrel Pharmacodynamics in Patients With ST-Segment-Elevation Myocardial Infarction.
    Cassese S; Kastrati A
    J Am Heart Assoc; 2020 Mar; 9(5):e015726. PubMed ID: 32122217
    [No Abstract]   [Full Text] [Related]  

  • 16. Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials.
    Bundhun PK; Shi JX; Huang F
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):80. PubMed ID: 29233189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of antiplatelet treatment in patients with coronary artery disease.
    Siasos G; Mourouzis K; Tousoulis D
    Hellenic J Cardiol; 2018; 59(6):344-346. PubMed ID: 29990542
    [No Abstract]   [Full Text] [Related]  

  • 18. Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
    Bonello L; Laine M; Camoin-Jau L; Noirot F; Guieu R; Dignat-George F; Paganelli F; Frere C
    Thromb Haemost; 2015 Oct; 114(4):702-7. PubMed ID: 26311415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?
    Cammisotto V; Biondi-Zoccai G; Frati G; Giordano A
    Am J Cardiovasc Drugs; 2019 Aug; 19(4):377-379. PubMed ID: 31030412
    [No Abstract]   [Full Text] [Related]  

  • 20. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.
    Wang Z; Zhou DY; Su Y; Si LY; Xu Q
    BMC Cardiovasc Disord; 2020 Mar; 20(1):130. PubMed ID: 32164560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.